Cite
MLA Citation
E Keystone et al.. “OP0086 The fully human anti-tnf monoclonal antibody, adalimumab (d2e7), dose ranging study: the 24-week clinical results in patients with active ra on methotrexate therapy (the armada trial).” Annals of the rheumatic diseases, vol. 60, n.d., p. A481. http://access.bl.uk/ark:/81055/vdc_100137791683.0x00005c